GB9426071D0 - Pharmaceutical compounds - Google Patents

Pharmaceutical compounds

Info

Publication number
GB9426071D0
GB9426071D0 GBGB9426071.8A GB9426071A GB9426071D0 GB 9426071 D0 GB9426071 D0 GB 9426071D0 GB 9426071 A GB9426071 A GB 9426071A GB 9426071 D0 GB9426071 D0 GB 9426071D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compounds
pharmaceutical
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9426071.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xenova Ltd
Original Assignee
Xenova Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xenova Ltd filed Critical Xenova Ltd
Priority to GBGB9426071.8A priority Critical patent/GB9426071D0/en
Publication of GB9426071D0 publication Critical patent/GB9426071D0/en
Priority to ZA9510903A priority patent/ZA9510903B/en
Priority to AU43101/96A priority patent/AU4310196A/en
Priority to GB9711211A priority patent/GB2310854B/en
Priority to IL11652295A priority patent/IL116522A0/en
Priority to PCT/GB1995/003028 priority patent/WO1996020179A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9426071.8A 1994-12-23 1994-12-23 Pharmaceutical compounds Pending GB9426071D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9426071.8A GB9426071D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds
ZA9510903A ZA9510903B (en) 1994-12-23 1995-12-21 Pharmaceutical compounds
AU43101/96A AU4310196A (en) 1994-12-23 1995-12-22 Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
GB9711211A GB2310854B (en) 1994-12-23 1995-12-22 Piperazine-2,5-dione derivatives as modulators of multi-drug resistance
IL11652295A IL116522A0 (en) 1994-12-23 1995-12-22 Piperazinedione derivatives their preparation and pharmaceutical compositions containing them
PCT/GB1995/003028 WO1996020179A1 (en) 1994-12-23 1995-12-22 Piperazine-2,5-dione derivatives as modulators of multi-drug resistance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9426071.8A GB9426071D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds

Publications (1)

Publication Number Publication Date
GB9426071D0 true GB9426071D0 (en) 1995-02-22

Family

ID=10766484

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9426071.8A Pending GB9426071D0 (en) 1994-12-23 1994-12-23 Pharmaceutical compounds

Country Status (5)

Country Link
AU (1) AU4310196A (en)
GB (1) GB9426071D0 (en)
IL (1) IL116522A0 (en)
WO (1) WO1996020179A1 (en)
ZA (1) ZA9510903B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9708805D0 (en) 1997-05-01 1997-06-25 Smithkline Beecham Plc Compounds
GB9810876D0 (en) 1998-05-20 1998-07-22 Smithkline Beecham Plc Compounds
ATE316969T1 (en) 1998-10-08 2006-02-15 Smithkline Beecham Plc TETRAHYDROBENZAZEPINE DERIVATIVES USABLE AS DOPAMINE D3 RECEPTOR MODULATORS (ANTIPSYCHOTIC AGENTS)
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US8710062B2 (en) * 2011-03-11 2014-04-29 Taipei Medical University Piperazinedione compounds
CN103396372B (en) * 2013-08-09 2015-05-20 中国科学院南海海洋研究所 2,5-diketopiperazine derivative, as well as preparation method and application thereof in preparing control agent for resisting marine fouling organisms

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69310367T2 (en) * 1992-07-10 1997-08-14 Glaxo Lab Sa ANILIDE DERIVATIVES
GB9217331D0 (en) * 1992-08-14 1992-09-30 Xenova Ltd Pharmaceutical compounds

Also Published As

Publication number Publication date
ZA9510903B (en) 1996-06-19
AU4310196A (en) 1996-07-19
WO1996020179A1 (en) 1996-07-04
IL116522A0 (en) 1996-03-31

Similar Documents

Publication Publication Date Title
GB9502874D0 (en) Pharmaceutical compounds
ZA959921B (en) Pharmaceutical compounds
GB9602080D0 (en) Pharmaceutical compounds
GB9410387D0 (en) Pharmaceutical compounds
GB9502861D0 (en) Pharmaceutical compounds
GB2286394B (en) Pharmaceutical compounds
ZA9510909B (en) Pharmaceutical compounds
GB9609976D0 (en) Pharmaceutical compounds
GB9418326D0 (en) Pharmaceutical compounds
GB9417102D0 (en) Pharmaceutical compounds
EP0923564A4 (en) Pharmaceutical compounds
GB9426071D0 (en) Pharmaceutical compounds
GB9426080D0 (en) Pharmaceutical compounds
GB9402805D0 (en) Pharmaceutical compounds
ZA956419B (en) Pharmaceutical compound
GB9426092D0 (en) Pharmaceutical compounds
GB9406052D0 (en) Pharmaceutical compounds
GB9417322D0 (en) Pharmaceutical compounds
SG32533A1 (en) Pharmaceutical compounds
ZA951176B (en) Pharmaceutical compounds
GB9417526D0 (en) Pharmaceutical compounds
ZA941781B (en) Pharmaceutical compounds
GB9426074D0 (en) Pharmaceutical compounds
GB9425040D0 (en) Pharmaceutical compounds
ZA944689B (en) Pharmaceutical compounds